Considering a Non-Oncology Target as a Route for Tumor Cell Killing With a Reduced Risk of Target Resistance
Time: 3:00 pm
day: Conference Day One
Details:
- Overcoming the growing concerns of ADC resistance through selecting less-specific targets such as the fibroblast
- Exploiting the fibroblast to engulf the ADC payload to then deliver the therapeutic to the neighboring tumor cells to initiate cell killing
- Concluding the longitudinal impact of such method on resistance as well as toxicity through such alternative routes of targeting